{
    "root": [
        {
            "id": 0,
            "parent": -1,
            "text": "ROOT",
            "relation": "null"
        },
        {
            "id": 1,
            "parent": 2,
            "text": "Background : <S>",
            "relation": "TEXTUAL-ORGANIZATION"
        },
        {
            "id": 2,
            "parent": 12,
            "text": "Human monoclonal antibodies ( mAbs )",
            "relation": "BACKGROUND"
        },
        {
            "id": 3,
            "parent": 2,
            "text": "generated as a result of the immune response",
            "relation": "CAUSE-RESULT"
        },
        {
            "id": 4,
            "parent": 2,
            "text": "are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases",
            "relation": "SAME-UNIT"
        },
        {
            "id": 5,
            "parent": 4,
            "text": "against which the immune response is protective . <S> <P>",
            "relation": "ELABORATION"
        },
        {
            "id": 6,
            "parent": 2,
            "text": "Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus",
            "relation": "ELABORATION"
        },
        {
            "id": 7,
            "parent": 6,
            "text": "that is the most serious pathogenic agent in transplant patients . <S>",
            "relation": "ELABORATION"
        },
        {
            "id": 8,
            "parent": 6,
            "text": "The available therapeutic armamentarium",
            "relation": "ELABORATION"
        },
        {
            "id": 9,
            "parent": 8,
            "text": "( e.g. HCMV hyperimmune globulins or antivirals )",
            "relation": "ELABORATION"
        },
        {
            "id": 10,
            "parent": 8,
            "text": "is associated with severe side effects and the emergence of drug - resistant strains ;",
            "relation": "SAME-UNIT"
        },
        {
            "id": 11,
            "parent": 8,
            "text": "therefore , neutralizing human mAb may be a decisive alternative in the prevention of primary and re - activated HCMV infections in these patients . <S> <P>",
            "relation": "CAUSE-RESULT"
        },
        {
            "id": 12,
            "parent": 0,
            "text": "The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors . <S>",
            "relation": "ROOT"
        },
        {
            "id": 13,
            "parent": 12,
            "text": "To this aim , we designed an efficient technology",
            "relation": "MANNER-MEANS"
        },
        {
            "id": 14,
            "parent": 13,
            "text": "relying on two discrete and sequential steps :",
            "relation": "ELABORATION"
        },
        {
            "id": 15,
            "parent": 13,
            "text": "first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ;",
            "relation": "ELABORATION"
        },
        {
            "id": 16,
            "parent": 15,
            "text": "second ,",
            "relation": "ELABORATION"
        },
        {
            "id": 17,
            "parent": 18,
            "text": "after both additives are removed ,",
            "relation": "TEMPORAL"
        },
        {
            "id": 18,
            "parent": 16,
            "text": "the cells are infected with EBV . <S>",
            "relation": "SAME-UNIT"
        },
        {
            "id": 19,
            "parent": 20,
            "text": "Using this strategy",
            "relation": "MANNER-MEANS"
        },
        {
            "id": 20,
            "parent": 13,
            "text": "we obtained 29 clones",
            "relation": "CAUSE-RESULT"
        },
        {
            "id": 21,
            "parent": 20,
            "text": "secreting IgG",
            "relation": "ELABORATION"
        },
        {
            "id": 22,
            "parent": 21,
            "text": "neutralizing the HCMV infectivity ;",
            "relation": "ELABORATION"
        },
        {
            "id": 23,
            "parent": 20,
            "text": "four among these were further characterized . <S>",
            "relation": "ELABORATION"
        },
        {
            "id": 24,
            "parent": 12,
            "text": "All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins ,",
            "relation": "FINDINGS"
        },
        {
            "id": 25,
            "parent": 24,
            "text": "currently used in transplant recipients . <S>",
            "relation": "ELABORATION"
        },
        {
            "id": 26,
            "parent": 24,
            "text": "Recombinant human monoclonal IgG1 suitable as a prophylactic or therapeutic tool in clinical applications has been generated . <S> <P>",
            "relation": "ELABORATION"
        },
        {
            "id": 27,
            "parent": 12,
            "text": "The technology described has proven to be more reproducible , efficient and rapid than previously reported techniques ,",
            "relation": "FINDINGS"
        },
        {
            "id": 28,
            "parent": 27,
            "text": "and can be adopted at low overall costs by any cell biology laboratory for the development of fully human mAbs for immunotherapeutic uses . <S> <P>",
            "relation": "JOINT"
        }
    ]
}